- "Pfizer
Completes Acquisition of
Anacor" (Press release). Pfizer. June 24, 2016 – via
Business Wire. "Pfizer to
Acquire Anacor Pharmaceuticals for $5.2B"....
-
prepared and
studied by X-ray crystallography.
Crisaborole was
developed by
Anacor Pharmaceuticals for the
topical treatment of psoriasis.
During preclinical...
- July 2014.
Originally developed by
Anacor, it is now
marketed in the
United States by
Novartis subsidiary Sandoz.
Anacor was paid US$65
million and also...
- (1968–2001)
Ambit (c.2010–2014)
Amersham plc (1946–2003)
Amylin (1987–2012)
Anacor (2002–2016)
Angiotech (1992–after 2017)
Antibe (2010–2024)
Antikamnia (1890–1930)...
- a
serial entrepreneur in the life
sciences industry. He has co-founded
Anacor Pharmaceuticals, Chemdex, NexPrise,
Virogen and FareWell. In
September 2020...
-
Acoziborole (SCYX-7158) is an
antiprotozoal drug
invented by
Anacor Pharmaceuticals in 2009, and now
under development by the
Drugs for
Neglected Diseases...
-
accessible from his homepage.
Original software development :
homals smacof anacor isotone aspect His more
current smacof and
homals software is on his GitHub...
-
Diseases in Lilongwe,
Malawi (AU-CTTBD).
Anacor Pharmaceuticals Inc, USA:
GALVmed is
funding research to
leverage Anacor’s boron chemistry platform to develop...
-
SmithKlineBeecham 2000–2006: Director,
Glaxo Smith Kline 2002:
Founded Anacor Pharmaceuticals, Inc. with Dr.
Stephen Benkovic, Penn
State University,...
-
Their low
systemic toxicity in
laboratory animals led to the
founding of
Anacor Pharmaceuticals by
Benkovic and Lucy
Shapiro that
developed and commercialized...
